Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 05-Mar-24 4:08 PM View:  | Leonard Frank X EVP, Pres., Novocure Oncology | Novocure Ltd (NVCR) | 04-Mar-24 | Sale | 840 | $16.01 | $13,448.40 | (< 1%) 160.94K to 160.1K | |
| 05-Mar-24 4:09 PM View: | Groenhuysen Wilhelmus Cm Chief Operating Officer | Novocure Ltd (NVCR) | 04-Mar-24 | Sale | 1,217 | $16.01 | $19,484.20 | (< 1%) 252.45K to 251.24K | |
| 05-Mar-24 4:09 PM View: | Groenhuysen Wilhelmus Cm Chief Operating Officer | Novocure Ltd (NVCR) | 01-Mar-24 | Sale | 2,107 | $16.03 | $33,768.70 | (< 1%) 254.56K to 252.45K | |
| 05-Mar-24 4:08 PM View: | Leonard Frank X EVP, Pres., Novocure Oncology | Novocure Ltd (NVCR) | 01-Mar-24 | Sale | 1,679 | $16.03 | $26,909.20 | (1%) 162.62K to 160.94K | |
| 29-Feb-24 4:38 PM View: | Leonard Frank X EVP, Pres., Novocure Oncology | Novocure Ltd (NVCR) | 28-Feb-24 | Sale | 2,078 | $16.14 | $33,544.70 | (1%) 164.69K to 162.62K | |
| 29-Feb-24 4:43 PM View: | Cordova Ashley Chief Financial Officer | Novocure Ltd (NVCR) | 27-Feb-24 | Grant | 102,249 | $16.30 | $1,666,660.00 | 87% 117.62K to 219.87K | |
| 29-Feb-24 10:00 PM View: | Puri Michal Nath Chief Human Resources Officer | Novocure Ltd (NVCR) | 27-Feb-24 | Grant | 71,574 | $16.30 | $1,166,660.00 | 190% 37.59K to 109.17K | |
| 29-Feb-24 4:35 PM View: | Weinberg Uri Chief Innovation Officer | Novocure Ltd (NVCR) | 27-Feb-24 | Grant | 81,799 | $16.30 | $1,333,320.00 | 92% 89.35K to 171.15K | |
| 29-Feb-24 4:33 PM View: | Giladi Moshe Chief Science Officer | Novocure Ltd (NVCR) | 27-Feb-24 | Grant | 51,124 | $16.30 | $833,321.00 | 274% 18.65K to 69.77K | |
| 29-Feb-24 10:00 PM View: | Leupin Nicolas Chief Medical Officer | Novocure Ltd (NVCR) | 27-Feb-24 | Grant | 51,124 | $16.30 | $833,321.00 | 100% 0 to 51.12K | |
| 29-Feb-24 4:30 PM View: | Ben Arye Barak General Counsel | Novocure Ltd (NVCR) | 27-Feb-24 | Grant | 81,799 | $16.30 | $1,333,320.00 | 232% 35.32K to 117.12K | |
| 29-Feb-24 4:38 PM View: | Leonard Frank X EVP, Pres., Novocure Oncology | Novocure Ltd (NVCR) | 27-Feb-24 | Grant | 102,249 | $16.30 | $1,666,660.00 | 164% 62.45K to 164.69K | |
| 29-Feb-24 4:30 PM View: | Ben Arye Barak General Counsel | Novocure Ltd (NVCR) | 31-Dec-23 | Grant | 128 | $12.69 | $1,624.32 | < 1% 35.2K to 35.32K | |
| 08-Nov-23 4:22 PM View: | Shah Pritesh Chief Growth Officer | Novocure Ltd (NVCR) | 07-Nov-23 | Sale (Planned) | 382 | $12.65 | $4,832.30 | (< 1%) 124.89K to 124.51K | |
| 02-Nov-23 4:20 PM View: | Cordova Ashley Chief Financial Officer | Novocure Ltd (NVCR) | 02-Nov-23 | Option Exercise | 175 | $11.46 | $2,005.50 | < 1% 117.44K to 117.62K | |
| 02-Nov-23 4:20 PM View: | Cordova Ashley Chief Financial Officer | Novocure Ltd (NVCR) | 31-Oct-23 | Option Exercise | 17,793 | $9.58 | $170,447.00 | 18% 99.65K to 117.44K | |
| 03-Nov-23 4:08 PM View: | Puri Michal Nath Chief Human Resources Officer | Novocure Ltd (NVCR) | 31-Oct-23 | Grant | 37,593 | -- | -- | 100% 0 to 37.59K | |
| 05-Sep-23 4:24 PM View: | Cordova Ashley Chief Financial Officer | Novocure Ltd (NVCR) | 01-Sep-23 | Sale | 883 | $21.82 | $19,264.60 | (< 1%) 100.53K to 99.65K | |
| 05-Sep-23 4:24 PM View: | Groenhuysen Wilhelmus Cm Chief Operating Officer | Novocure Ltd (NVCR) | 01-Sep-23 | Sale | 294 | $21.82 | $6,414.26 | (< 1%) 210.12K to 209.82K | |
| 05-Sep-23 4:23 PM View: | Shah Pritesh Chief Growth Officer | Novocure Ltd (NVCR) | 01-Sep-23 | Sale | 273 | $21.82 | $5,956.10 | (< 1%) 125.17K to 124.89K | |
| 04-Aug-23 4:02 PM View: | Cordova Ashley Chief Financial Officer | Novocure Ltd (NVCR) | 02-Aug-23 | Sale | 1,144 | $30.25 | $34,607.30 | (1%) 101.68K to 100.53K | |
| 06-Jul-23 4:13 PM View: | Ben Arye Barak General Counsel | Novocure Ltd (NVCR) | 30-Jun-23 | Grant | 288 | $35.28 | $10,160.60 | < 1% 34.91K to 35.2K | |
| 06-Jul-23 4:13 PM View: | Cordova Ashley Chief Financial Officer | Novocure Ltd (NVCR) | 30-Jun-23 | Grant | 367 | $35.28 | $12,947.80 | < 1% 101.31K to 101.68K | |
| 06-Jul-23 4:14 PM View: | Groenhuysen Wilhelmus Cm Chief Operating Officer | Novocure Ltd (NVCR) | 30-Jun-23 | Grant | 366 | $35.28 | $12,912.50 | < 1% 209.75K to 210.12K | |
| 06-Jul-23 4:12 PM View: | Danziger Asaf Chief Executive Officer Director | Novocure Ltd (NVCR) | 30-Jun-23 | Grant | 367 | $35.28 | $12,947.80 | 3% 13.62K to 13.99K | |
| 06-Jul-23 4:14 PM View: | Shah Pritesh Chief Growth Officer | Novocure Ltd (NVCR) | 30-Jun-23 | Grant | 367 | $35.28 | $12,947.80 | < 1% 124.8K to 125.17K | |
| 06-Jul-23 4:14 PM View: | Burke William Patrick Chief Human Resources Officer | Novocure Ltd (NVCR) | 30-Jun-23 | Grant | 357 | $35.28 | $12,595.00 | < 1% 66.09K to 66.45K | |
| 09-Jun-23 4:04 PM View: | Leung Gabriel Director | Novocure Ltd (NVCR) | 07-Jun-23 | Grant | 3,853 | -- | -- | 5% 75.29K to 79.14K | |
| 09-Jun-23 4:05 PM View: | Scannell Timothy J Director | Novocure Ltd (NVCR) | 07-Jun-23 | Grant | 3,853 | -- | -- | 5137% 75 to 3.93K | |
| 09-Jun-23 4:05 PM View: | Vernon W Anthony Director | Novocure Ltd (NVCR) | 07-Jun-23 | Grant | 3,853 | -- | -- | 2% 161.94K to 165.8K | |
| 07-Mar-23 4:52 PM View: | Leonard Frank X President, CNS Cancers US | Novocure Ltd (NVCR) | 07-Mar-23 | Sale | 8,318 | $75.16 | $625,205.00 | (13%) 62.6K to 54.28K | |
| 06-Mar-23 4:37 PM View: | Leonard Frank X President, CNS Cancers US | Novocure Ltd (NVCR) | 03-Mar-23 | Grant | 11,808 | -- | -- | 20% 58.14K to 69.95K | |
| 07-Mar-23 4:51 PM View: | Cordova Ashley Chief Financial Officer | Novocure Ltd (NVCR) | 03-Mar-23 | Private Sale | 5,505 | $76.16 | $419,258.00 | (5%) 106.81K to 101.31K | |
| 07-Mar-23 4:51 PM View: | Groenhuysen Wilhelmus Cm Chief Operating Officer | Novocure Ltd (NVCR) | 03-Mar-23 | Private Sale | 25,635 | $76.16 | $1,952,350.00 | (11%) 235.39K to 209.75K | |
| 07-Mar-23 4:52 PM View: | Leonard Frank X President, CNS Cancers US | Novocure Ltd (NVCR) | 03-Mar-23 | Private Sale | 5,291 | $76.16 | $402,959.00 | (8%) 67.89K to 62.6K | |
| 06-Mar-23 4:43 PM View: | Weinberg Uri Chief Innovation Officer | Novocure Ltd (NVCR) | 03-Mar-23 | Grant | 32,766 | -- | -- | 58% 56.28K to 89.04K | |
| 06-Mar-23 4:41 PM View: | Shah Pritesh Chief Growth Officer | Novocure Ltd (NVCR) | 03-Mar-23 | Grant | 47,182 | -- | -- | 48% 99.04K to 146.22K | |
| 07-Mar-23 4:52 PM View: | Shah Pritesh Chief Growth Officer | Novocure Ltd (NVCR) | 03-Mar-23 | Private Sale | 21,421 | $76.16 | $1,631,410.00 | (15%) 146.22K to 124.8K | |
| 06-Mar-23 4:40 PM View: | Cordova Ashley Chief Financial Officer | Novocure Ltd (NVCR) | 03-Mar-23 | Grant | 11,808 | -- | -- | 12% 95.01K to 106.81K | |
| 07-Mar-23 4:50 PM View: | Burke William Patrick Chief Human Resources Officer | Novocure Ltd (NVCR) | 03-Mar-23 | Private Sale | 593 | $76.16 | $45,162.50 | (< 1%) 66.68K to 66.09K | |
| 06-Mar-23 4:40 PM View: | Groenhuysen Wilhelmus Cm Chief Operating Officer | Novocure Ltd (NVCR) | 03-Mar-23 | Grant | 51,986 | -- | -- | 28% 183.4K to 235.39K | |
| 06-Mar-23 4:37 PM View: | Leonard Frank X President, CNS Cancers US | Novocure Ltd (NVCR) | 03-Mar-23 | Sale | 2,059 | $77.64 | $159,859.00 | (3%) 69.95K to 67.89K | |
| 03-Mar-23 4:13 PM View: | Leonard Frank X President, CNS Cancers US | Novocure Ltd (NVCR) | 02-Mar-23 | Private Sale | 4,107 | $75.38 | $309,578.00 | (7%) 63.09K to 58.99K | |
| 06-Mar-23 4:42 PM View: | Burke William Patrick Chief Human Resources Officer | Novocure Ltd (NVCR) | 02-Mar-23 | Private Sale | 281 | $75.28 | $21,153.10 | (< 1%) 66.96K to 66.68K | |
| 06-Mar-23 4:37 PM View: | Leonard Frank X President, CNS Cancers US | Novocure Ltd (NVCR) | 02-Mar-23 | Private Sale | 844 | $75.28 | $63,534.50 | (1%) 58.99K to 58.14K | |
| 06-Mar-23 4:40 PM View: | Cordova Ashley Chief Financial Officer | Novocure Ltd (NVCR) | 02-Mar-23 | Private Sale | 1,055 | $75.28 | $79,418.20 | (1%) 96.06K to 95.01K | |
| 06-Mar-23 4:40 PM View: | Groenhuysen Wilhelmus Cm Chief Operating Officer | Novocure Ltd (NVCR) | 02-Mar-23 | Private Sale | 1,213 | $75.28 | $91,312.10 | (< 1%) 184.62K to 183.4K | |
| 06-Mar-23 4:41 PM View: | Shah Pritesh Chief Growth Officer | Novocure Ltd (NVCR) | 02-Mar-23 | Private Sale | 937 | $75.28 | $70,535.40 | (< 1%) 99.97K to 99.04K | |
| 02-Mar-23 4:55 PM View: | Cordova Ashley Chief Financial Officer | Novocure Ltd (NVCR) | 01-Mar-23 | Sale | 2,198 | $76.36 | $167,845.00 | (2%) 98.26K to 96.06K | |
| 02-Mar-23 4:49 PM View: | Groenhuysen Wilhelmus Cm Chief Operating Officer | Novocure Ltd (NVCR) | 01-Mar-23 | Sale | 2,164 | $76.36 | $165,248.00 | (1%) 186.78K to 184.62K |
